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At one major urban academic medical center, patients aged 50 years and older with fragility fractures were identiﬁed and
scheduled or assisted in referral into osteoporosis medical management appointments. We evaluated the eﬃcacy of an active
intervention program at overcoming the logistical barriers and improving proper osteoporosis follow-up for persons who have
sustained a fragility fracture. Of 681 patients treated for deﬁned fractures, 168 were eligible and consented for the study of
fragility fractures. Of those enrolled, 91 (54.2%) had appropriate osteoporosis follow-up on initial interview, and overall 120
(71.4%) had successful osteoporosis follow-up following our active intervention. Seventy patients (41.7%) were deemed to have
no osteoporosis follow-up, and, of these, 48 were successfully referred to a scheduling coordinator. The scheduling coordinator
was able to contact 37 (77%) patients to schedule proper follow-up, and, of these, 29 (78.4%) conﬁrmed receiving an appropriate
follow-up appointment. Active intervention and assisted scheduling for patients with recent fragility fractures improved the self-
reported rate of osteoporosis follow-up from 54.2% to 71.4%.
1.Introduction
Osteoporosis is a worldwide public health problem that is
preventable and treatable with appropriate medical follow-
up and care. It is the primary etiology of fragility fractures
among the elderly and represents a signiﬁcant factor of mor-
bidity and mortality within this population. Despite sub-
stantial evidence that a prior fragility fracture results in an
increased risk of a subsequent fracture, less than 30% of
postmenopausalwomenandlessthan10%ofmenwithprior
fracture are treated for osteoporosis [1–3].
With increasing life expectancy and a concomitant
growth in the proportion of the elderly population, fracture
incidence is expected to increase 2- to 4-fold in the next
decade [1]. As a prior history of fracture is one of the biggest
risk factors for future fractures, eﬀective interventions to
improve osteoporosis care in this particular at-risk patient
population are needed.
The aim of this interventional study was to evaluate a
largeacademicinstitution’sactiveprogramtoimproveosteo-
porosis follow-up after being treated for a fragility fracture.
Wehypothesizedthatbyidentifying, activelyscheduling,and
referring these patients, we could improve the rate of osteo-
porosis follow-up treatment over current national ﬁgures.
2. Methods
The eligible study population included patients over the
age of 50 years with fragility fractures treated at an ortho-
paedic hospital in Los Angeles, CA between April, 2009
and March, 2010. Potential study subjects were identiﬁed
by ICD-9 codes representing the following fracture types:
(1) vertebral column 805.8; (2) pubis 808.2; (3) humerus
812.00; (4) distal radius 813.42; (5) femoral neck 820.00;
(6) pertrochanteric, open 820.03; (7) pertrochanteric, closed
820.20; (8) intertrochanteric 820.21; (9) subtrochanteric2 Journal of Osteoporosis
Table 1: ICD-9 codes and number of study patients corresponding
to deﬁned fragility fractures.
ICD-9 Code Fracture N
805.8 Vertebral column 39
808.2 Pubis 19
812.00 Humerus 6
813.42 Distal radius 37
820.00 Femoral neck 1
820.03 Pertrochanteric, open 0
820.20 Pertrochanteric, closed 2
820.21 Intertrochanteric 34
820.22 Subtrochanteric 6
820.80 Unspeciﬁed part of femoral neck, closed 24
820.22; (10) unspeciﬁed part of femoral neck, closed 820.80
(Table 1). Additional inclusion criteria were age greater than
50 years for females and 55 years for males and a fracture
sustained during a low-energy fall (fall from standing height
or less). Exclusion criteria were fractures sustained as a result
of a primary or metastatic tumor or high-energy mech-
anism (e.g., motor vehicle accident) and if the patient was
deceased,unabletocommunicateinEnglish,unabletoclear-
ly communicate (e.g., due to dementia, other), refused to
participate in the study, or was unavailable for interview
following 3 separate telephone attempts.
Between April 2009 and March 2010, 681 patients treat-
ed for the fractures described above were treated at our
institution. Based on fragility fracture study criteria, initial
telephone screening of 520 fragility fracture patients was
performed by three research staﬀ within 8–12 weeks of the
patient’s discharge date. Three hundred and thirty patients
were ineligible for study: 253 were below inclusion age
criteria, 6 were deceased, 16 were too ill, 8 denied having a
fracture, 9 were unable to communicate in English, 9 report-
ed having a fracture due to high-energy trauma, 3 were con-
sidered to have a pathologic fracture, and 26 were not
included for reasons including having an incorrectly coded
discharge diagnosis or previous history of fracture that
occurred outside of the study period. Of the 681 patients
treatedfortheabovefractures,161(37.6%)wereunabletobe
contacted following 3 separate telephone attempts, leaving
351 patients eligible for fragility fracture study. One hundred
ninety patients (36.5%) were successfully contacted and
deemed eligible to participate in the study. Twenty-two
(11.6%)refusedtoparticipate.Oncethepatientconsentedto
study participation, a telephone-administered questionnaire
(Table 2) was used to identify those fragility fracture patients
who were not medically treated or who did not have osteo-
porosis follow-up care within 8–12 weeks following initial
fracture. Researchers recorded the responses to a 5-point
questionnaire in a unique password-protected spreadsheet.
If patients answered “no” to question 3 (“Are you currently
seeing a primary care doctor or osteoporosis specialist for
your bone health?”) and a successive “no” to question 5 of
the telephone script (“Are you currently being treated for
osteoporosis?”), they were deemed to have insuﬃcient or no
Table 2: Initial telephone script used to survey patients who
sustained a fragility fracture 6–8 weeks after hospital encounter.
(1) Do you know what osteoporosis is?
(a) Yes
(b) No
(c) Not sure
If answers (b) or (c), then read: let me explain
osteoporosis and how it may relate to you. Osteoporosis is
a disease that makes the bones in the body fragile. Some
people have this disease and do not know it. Because you
have had a fracture, you are at higher risk of fracturing
again.
(2) Have you ever been diagnosed with osteoporosis?
(a) Yes
(b) No
(3) Are you currently seeing a primary care doctor or osteoporosis
specialist for your bone health?
(a) Yes
(b) No
(C) I do not know
(4) Have you had a bone density study performed since your
fracture?
(a) Yes
(b) No
(c) I do not know
(5) Are you currently being treated for osteoporosis?
(a) Yes
If yes, please specify prescription treatment (medication).
FDA approved: bisphosphonates [fosamax (alendronate),
actonel (risedronate), boniva (ibandronate), reclast
(zoledronic acid)]; estrogen replacement therapy; evista
(raloxifene); Forteo (teriparaitide); miacalcin nasal spray
(only for vertebral fractures)
(b) No
(c) I do not know
Education: The fracture (broken bone) that you sustained is associated with
osteoporosis. Osteoporosis is a disorder of bones that results in weakened
bones that are more susceptible to fracturing (breaking). Having sustained
a break in your bone like you have this time places you at a signiﬁcant
increased risk for breaking a bone again in the future if you do not
seek treatment. The National Osteoporosis Foundation recommends that
patients who have had an osteoporotic fracture (as is likely in your case)
have a bone density study and be placed on a prescription medication to
prevent further fractures. The UCLA Department of Orthopaedic Surgery
recommends that you have a follow-up visit with your primary care
physician or specialist for your osteoporosis. A representative from the
Osteoporosis Center will be contacting you to make an appointment in the
near future.
osteoporosis follow-up care. Appropriate follow-up care in
our initial and closeout interviews included vitamin D and
calcium, and/or a bisphosphonate, a completed or scheduled
appointment with a physician regarding osteoporosis, or a
completed or scheduled DXA scan. These patients’ names
and contact information were recorded in a separate referral
list for intervention. Patients who responded “yes” to ques-
tion 3 or 5 were counted as receiving appropriate care.
For the active intervention, the eligible patient list was
t r a n s f e r r e do naw e e k l yb a s i st oa no ﬃce administrator who
then recontacted the patient to authorize, schedule, and
refer patients to their primary care doctor, an osteoporosis
specialist, or the institution’s osteoporosis center.Journal of Osteoporosis 3
Table 3: Follow-up telephone script used to contact patients who
were deemed to have insuﬃcient screening and treatment following
a deﬁned fragility fracture. Conducted 12–14 weeks after hospital
encounter or 6 weeks following initial telephone interview.
(1) Did you receive follow-up care for osteoporosis since our
initial phone call?
(a) Yes (proceed to question 3)
(b) No
(2) Do you have a future appointment scheduled to follow-up on
your osteoporosis?
(a) Yes (If so, when): ... (skip to bottom of questionnaire
and thank patient for his/her time).
( b )N o( I fn o ,s k i pt oq u e s t i o n6 )
(3) Did you see your primary care physician or an osteoporosis
specialist?
(a) Primary care physician
(b) Osteoporosis specialist
(c) Both
(4) Did you or are you planning to have a bone density scan done?
(a) Yes
(b) No
(c) I do not know
(5) Are you currently being treated for osteoporosis?
(a) Yes (Please specify treatment): ...
(b) No
(6) Only if answered No on question 2: Is the reason for not seeing
a primary care physician or osteoporosis specialist because of
insurance issues?
(a) Yes
(b) No
To assess the eﬀectiveness of the active intervention, the
3 research staﬀ members administered a closeout interview
(e.g., second telephone interview) consisting of a six-ques-
tion standardized telephone script (Table 3) approximately
6–8 weeks after the ﬁrst telephone interview. All patients
who were contacted in the active intervention phase were
eligible and contacted for a closeout interview. If the patient
answered “yes” to question 1 (Did you receive follow-up care
forosteoporosissinceourinitialphonecall?),question2(Do
you have a future appointment scheduled to follow-up on
your osteoporosis?), question 4 (Did you or are you planning
to have a bone density scan done?) or question 5 (Are you
currently being treated for osteoporosis?), the patient was
determined to have achieved proper osteoporosis follow-up
and/orcare.WeusedChi-squaredor2-sidedStudent’st-tests
diﬀerence of the characteristics between those who reported
being treated for osteoporosis or at least seeing a MD for
osteoporosis and those who did not. SAS Software was used
for all analyses (SAS Institute, version 9.1, Cary, NC). The
above study protocol was approved by our Institutional
Review Board.
3. Results
Overall, 168 out of 190 (88%) eligible patients consented
to participate in the study and were initially queried as to
their awareness of osteoporosis and follow-up care achieved
Table 4: Characteristics and interview data of study participants at
baseline.
Age 77.5 ± 11.0
Sex, N (% female) 132 (78.6%)
Initial interview: N (% Yes)
Know what osteoporosis is? 144 (85.7%)
Diagnosed with osteoporosis? 67 (39.9%)
S e e i n gap r i m a r yc a r ed o c t o ro ro s t e o p o r o s i s
specialist for bone health? 87 (51.8%)
Ever had bone density study performed since
fracture? 40 (23.8%)
Being treated for osteoporosis? 67 (39.9%)
following their fragility fracture. The study patients’ mean
age was 77 (SD = 11) years. One hundred and thirty-two
(79%)werefemaleand36weremale(Table 4).Mostpatients
in our study sample experienced hip fractures (n = 67), with
the remainder of study patients having sustained vertebral
fractures (n = 39), wrist or humeral fractures (n = 43), or
pelvic fractures (n = 19). Among the enrolled study partic-
ipants, 91 (54.2%) were found after data analysis to either
have MD follow-up for their osteoporosis or were being
treated for osteoporosis. Those who reported being treated
forosteoporosis oratleastseeing aMDforosteoporosis were
more likely to be females than males (80/91; P = 0.0004).
Seventy patients (41.2%) were deemed to have insuﬃcient
follow-up following a fragility fracture and were referred to
our study coordinator for the active intervention program
(Figure 1). Ninety-one percent of these patients with no
treatment following a fragility fracture were unaware of the
association of their fracture with osteoporosis.
Seventy-eight percent of the enrolled patients entered
into the active intervention program and successfully recon-
tacted after the initial telephone screening achieved proper
medical treatment or follow-up for osteoporosis (29/37).
By the closeout interview, 19 patients had already received
follow-up care and were being treated by their primary
care provider or osteoporosis specialist. Nine patients had a
conﬁrmed appointment scheduled with the institution Oste-
oporosis Center, 5 had scheduled appointments with outside
providers for bone health, and 4 had scheduled appoint-
ments for a DXA scan. Our study osteoporosis follow-up
rate following initial interview was 54.2% (91/168), and,
with an improvement of 17.2% (29/168) following active
intervention, our study overall osteoporosis follow-up rate
was 71.4%.
4. Discussion
A number of interventional studies have attempted to
increase rates of screening and treatment for osteoporosis
with varying success. One of the key barriers has been the
low rates of referral by orthopaedic surgeons to osteoporosis
services and primary care physicians for secondary preven-
tion of fragility fractures [4]. In the majority of these studies,
emergencyroompersonnelornurseassistantsconductedthe4 Journal of Osteoporosis
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Figure 1: Flow chart of study enrollment and success.
interventions. Orthopaedic surgeons have conducted osteo-
porosis interventions in the inpatient and outpatient clinical
setting[5–8];however,toourknowledge,nopublishedstud-
ieshaveexaminedthesuccessofasimpletelephoneinterven-
tion on osteoporosis treatment following a fragility fracture.
In a prospective, randomized trial involving 80 patients
admitted to an academic medical center for a low-energy
fracture, Gardner et al. conducted 15-minute discussions
withpatientsregardingtheassociationbetweentheirfracture
and osteoporosis [5]. Upon discharge, these patients were
provided with 5 questions regarding osteoporosis treatment
to be given to their primary care providers and were remind-
ed about the questions during a telephone follow-up call six
weeks after discharge. Patients in the control group received
an informational brochure describing methods for fall
prevention. The authors concluded that patients in the study
group had signiﬁcantly higher rates of osteoporosis follow-
up compared to the control group (P = 0.04). Though
osteoporosis education and intervention in an inpatient
setting by orthopaedic surgeons is ideal and has been
demonstrated to be eﬀective, it is diﬃcult to standardize the
quality and compliance of this intervention in a large aca-
demic institution, where residents and nurse practitioners
often complete the discharge process.
The rate of osteoporosis follow-up following a fragility
fracture has been reported to be between 19% and 76% with
the use of clinical intervention protocols. One recent study
from Spain that examined long-term compliance with bis-
phosphonate treatment reported the most promising results.
Ojeda-Bruno et al. utilized an educational system, telephone
follow-up, and scheduled follow-up visits to determine the
eﬀect of their intervention on long-term compliance with
bisphosphonate treatment. In this study, patients who sus-
tained a fragility fracture, based on inclusion criteria similar
to that of our study, were scheduled for an oﬃce visit for
osteoporosis assessment. Of all patients eligible for the study,
a randomly selected intervention group also received a two-
hour education session given by a nurse or physician regard-
ing bone health. Two additional clinical visits were scheduled
over a one-year period for all study participants. While
the authors found that only 20% of the group randomized
to the intervention attended the educational session, theyJournal of Osteoporosis 5
concluded that it was the baseline oﬃce visit for patients
determinedtobeatriskforosteoporosisthatwasresponsible
for increasing the frequency of bisphosphonate use from
17% before consultation to 76% after the initial visit [9].
Thesestudy results support the premise ofourstudy that just
ensuring proper outpatient oﬃce follow-up appointments
will result in improved post-fragility-fracture care and are
consistent with the 2011 Healthcare Eﬀectiveness Data
and Information Set (HEDIS) Guidelines for osteoporosis
management that recommend postmenopausal women (67
years of age and older) who have had a low-impact fracture
b er e f e r r e df o raD X Ao rp r e s c r i p t i o nf o rad r u gt ot r e a t
osteoporosis within six months of the their fracture [10].
In another inpatient study conducted on all patients
hospitalized with a fragility fracture, Collinge et al. utilized
calcaneal quantitative ultrasound (QUS) to stratify patients
by low, moderate, and high risk for osteoporosis [11]. For
patients identiﬁed as high risk, intervention was initiated
with patient education and calcium and vitamin D therapy.
Education consisted of a 15–20-minute meeting with a nurse
clinician about osteoporosis and a one-page summary of
references to obtain more information. Upon discharge, a
prescription for calcium and vitamin D, a summary of their
QUS test results, and instructions to follow up with their
primary care physician were provided. At 12 months after
discharge, 57% of high-risk patients had seen their primary
care physician for a bone health discussion. The authors
concluded that although patient education is key, the eﬃcacy
of any intervention program ultimately depends on patient
compliance and attributed lack of follow-up to limited access
to a primary care provider, lack of money for follow-up, and
belief that follow-up was not important.
In the American Orthopaedic Association “Own the
Bone”Initiative,whichwasthebasisforourpilotandpresent
study, a quality-based improvement registry was utilized to
initiate and improve patient education strategies involving
osteoporosiseducation,prevention,diagnosis,andtreatment
[4]. Thoughthe study wasunableto demonstratean increase
use in DXA screening or use of pharmacotherapy, it did ﬁnd
that establishment of an ancillary team to support osteo-
porosis care was key. It suggested that orthopaedic surgeons
are not used to obtaining and often do not have the time to
obtain a detailed patient history that includes data on oste-
oporosisriskfactors,currentmedication,andcomorbidcon-
ditions.
In a follow-up study to “Own the Bone,” Edwards and
colleagues conducted a prospective cohort study at two
diﬀerent hospitals to assess the eﬀectofimmediatetreatment
for osteoporosis, which included initiation of pharmacologic
therapy during hospitalization, as compared to delayed care
[8]. In the delayed care group, the orthopaedic surgery team
recommended osteoporosis counseling, DXA, and potential
treatment for their osteoporosis that was communicated to
the patient’s primary care physician after hospital discharge.
Although the rate of osteoporosis treatment of patients with
a fragility fracture increased when an orthopaedic surgeon
intervened in either group, the highest success rate for treat-
ment was experienced with immediate initiation of osteo-
porosis care during hospitalization for the fragility fracture,
resulting in sixty-seven percent of the patients receiving ther-
apy six months after fracture, compared to delayed initiation
of treatment which was only thirty percent when referred
back to the primary care physician [8]. Similar to the Gard-
ner et al. study [5], the value of having an inpatient ortho-
paedic surgery team that is educated in osteoporosis man-
agement initiate treatment while hospitalized for the fragility
fracture is highlighted. Further educational eﬀorts should
be explored within the American Academy of Orthopaedic
Surgery, the American Orthopaedic Association, and other
orthopaedic surgery organizations to educate orthopaedic
surgeons in the area of osteoporosis management, especially
in the post-fragility-fracture patient.
Within the Department of Orthopaedic Surgery at our
institution, following our active intervention program, we
appreciated increased rates of osteoporosis screening and
treatment among patients who sustained a fragility fracture
thatcouldbesustainablewitharatherminimalincreaseduse
of existing resources. While there exist reported successful
interventionsinclinicalsettingsbyorthopaedicsurgeons,the
associatedcostsofpersonnelandmaterialsandotherbarriers
presented in the literature led us to create a simple protocol
utilizing few resources, time, and costs. First, we obtained
basic patient medical information from the screening of
fragility fracture ICD-9 codes from our institution’s billing
department on a monthly basis at no extra cost. Then,
unpaid research staﬀ (medical students) administered a tele-
phone-screening questionnaire to determine whether pa-
tients had appropriate osteoporosis follow-up care. Those
patients without osteoporosis follow-up were then referred
to a scheduling coordinator who was compensated $8,000
over the course of the year to authorize, refer, or schedule
patientsforosteoporosistreatment.Baseduponthenumbers
of patients ultimately scheduled, the actual costs of our
intervention were $275.86 per patient. The majority of
the cost-eﬀectiveness data on osteoporosis interventions are
presented in costs per quality-adjusted life years (QALYs)
[12]. Our study was not designed to assess cost-eﬀectiveness.
However, if our intervention were to be continually imple-
mented at our institution or other practice settings, the
costs would be higher because of the initial time and costs
involved in contacting the patients to assess osteoporosis
awareness and follow-up care. However, based on facts that
osteoporosiscauses1.5millionfracturesintheUSAannually,
with an estimated cost of treating at $17 billion, and a
reported mortality rate of 24% in the ﬁrst year following a
hip fracture [13], our intention in conducting such a study
was to gain departmental and institutional awareness so that
some ﬁnancial resources might be directed towards develop-
ing an eﬀective fracture intervention program.
Our study had some limitations. First, there was a high
rate of data drop-oﬀ between the researchers and scheduling
coordinator. Despite the 70 patients that met criteria for
referral to the scheduling coordinator, only 48 patients were
referred.Thereasonsforthisarelikelytwofold:(1)therewere
three diﬀerent student researchers who collected their own
data in password-protected ﬁles that were not collated until
the end of the study period so that missing referrals were not
detecteduntilbeyondthestudy’stimeline;(2)thescheduling6 Journal of Osteoporosis
coordinator was not given the original patient eligibility list
and had no way of tracking whether or not patients might
or might not have been appropriately referred. To minimize
this data drop-oﬀ, a single follow-up coordinator respon-
sible for data management should be appointed to ensure
that appropriate patient follow-up is achieved. A second
limitation is that our study population was likely not rep-
resentative of most fragility fracture patient populations.
First, our participation rate was very high at 88%. Second,
the self-reported osteoporosis follow-up care was about 30%
higher than the national average, indicating that our patient
population might have been more willing to comply with
follow-up recommendations than the general population or
may have better access to a primary care physician [14].
Orthopaedic surgeons have a unique opportunity to
improve osteoporosis care for their patients with a fragility
fracture through assessment, education, simple treatment
measures, and, most importantly, a referral for long-term
osteoporosis management. Our telephone-based interven-
tion demonstrated that a simple protocol, not based upon
a speciﬁc orthopaedic surgeon’s referral, was relatively inex-
pensive and leads to increased osteoporosis evaluation and
treatment in patients with fragility fractures.
With further centralized coordination and continued
implementation of our protocol, we will plan to further
evaluate the success and sustainability of this program at our
institution with the hopes that our practical experience may
be generalized to other orthopaedic surgery departments.
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